Advertisement
U.S. markets open in 6 hours 54 minutes

Intelligent Bio Solutions Inc. (INBS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
5.57+0.05 (+0.91%)
At close: 04:00PM EST
5.50 -0.07 (-1.26%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close5.52
Open5.41
Bid0.00 x 1000
Ask0.00 x 1100
Day's Range5.08 - 5.60
52 Week Range2.28 - 77.04
Volume172,548
Avg. Volume3,577,766
Market Cap11.963M
Beta (5Y Monthly)4.88
PE Ratio (TTM)0.09
EPS (TTM)65.15
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est111.60
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for INBS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Intelligent Bio Solutions Inc.
    Daily – Vickers Top Buyers & Sellers for 06/23/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    8 months agoArgus Research
View more
  • GlobeNewswire

    Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024

    NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will present at the Emerging Growth Conference on March 6, 2024. INBS will provide an update on the Company’s growth and financial performance in 2023, among other topics. Spiro Sakiris, INBS’ Chief Financial Officer, is scheduled to present from 3:40 p.m. to 3:50 p

  • GlobeNewswire

    Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway

    NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its partnership with Cliantha Research, a full-service Clinical Research Organization (CRO), to perform a pharmacokinetic (PK) study forming part of the Company’s FDA 510(k) clinical study plan. The Company’s PK study will recruit 40 healthy adult subjects under an IRB/EC an

  • GlobeNewswire

    Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders’ Equity Requirement

    NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that on February 13, 2024, it received written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires that the Company's common stock maint